Valuation: Brainsway Ltd

Market Cap 584M 0 500M 469M 428M 808M 55.63B 816M 5.53B 2.15B 28.07B 2.19B 2.14B 92.95B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 584M 0 500M 469M 428M 808M 55.63B 816M 5.53B 2.15B 28.07B 2.19B 2.14B 92.95B EV / Sales 2026 *
8.49x
EV / Sales 2027 * 6.94x
Free-Float
90.5%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 54 12/02/2023
Chief Tech/Sci/R&D Officer 56 30/04/2006
Director of Finance/CFO 50 22/05/2023
Director TitleAgeSince
Chairman 74 31/12/2002
Director/Board Member 70 31/10/2006
Director/Board Member 56 16/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%-6.36% - - 584M
-0.12%+2.58%+28.84%+15.44% 232B
-0.05%+1.76%+4.35%-17.69% 152B
-0.40%-7.00%-22.01%+22.68% 131B
-4.71%-7.75%-54.90%-10.80% 72.26B
-0.39%-1.25%-16.43%-13.70% 51.57B
+1.18%-1.22%+12.16%+19.89% 52.38B
-0.57%-0.95%+30.12%+28.36% 43.71B
+0.10%-0.45%+39.79%+47.09% 40.72B
+0.47%+10.95%+130.37%+43.77% 33.97B
Average -0.49%+3.90%+16.92%+15.00% 90.01B
Weighted average by Cap. -0.47%+3.71%+9.45%+9.97%

Financials

2026 *2027 *
Net sales 68.73M 0 58.89M 55.18M 50.41M 95.13M 6.55B 96.07M 651M 253M 3.31B 258M 252M 10.95B 84.08M 0 72.04M 67.51M 61.66M 116M 8.02B 118M 796M 310M 4.04B 316M 309M 13.39B
Net income 10.9M 0 9.34M 8.75M 7.99M 15.09M 1.04B 15.24M 103M 40.19M 524M 40.93M 40.04M 1.74B 20.11M 0 17.23M 16.15M 14.75M 27.84M 1.92B 28.11M 190M 74.15M 967M 75.52M 73.87M 3.2B
Net Debt - -
Logo Brainsway Ltd
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
-